发明名称 |
Methods and compositions for treating dry eye disease and other eye disorders |
摘要 |
The present invention discloses pharmaceutical preparations for treatment of eye disorders containing an alpha 2 adrenergic agonist, to processes for producing the pharmaceutical preparations and methods for treatment of various eye disorders including dry eye and Meibomian gland dysfunction and a medicinal applicator for topical application of an alpha 2 adrenergic agonist to a subject, a package assembly for the medicinal applicator and methods of using the medicinal applicator to treat eye disorders. |
申请公布号 |
US9597328(B2) |
申请公布日期 |
2017.03.21 |
申请号 |
US201615051654 |
申请日期 |
2016.02.23 |
申请人 |
Ocugen, Inc.;The Board of Trustees of the University of Illinois |
发明人 |
Jain Sandeep;Kompella Uday Bhaskar;Musunuri Shankar |
分类号 |
A61K9/14;A61K31/498;A61K31/573;A61K9/00;A61K9/107;A61K9/06;A61K47/32;A61K47/36;A61K47/38;A61K9/08 |
主分类号 |
A61K9/14 |
代理机构 |
Hamilton DeSanctis & Cha, LLP. |
代理人 |
Cha Don D.;Hamilton DeSanctis & Cha, LLP. |
主权项 |
1. A method of treating a patient suffering from a dry eye syndrome comprising administering to an eye of the patient in need of such a treatment an ophthalmological pharmaceutical formulation comprising nanoemulsion of oil, a therapeutically effective amount of an active ingredient for treating a dry eye syndrome, wherein said active ingredient consists of an alpha 2 adrenergic agonist having a higher alpha 2A agonist activity compared to alpha 2B agonist activity or a pharmaceutically acceptable salt thereof. |
地址 |
Malvern PA US |